Literature DB >> 6758493

Prevalence of retinopathy and proteinuria in type 1 diabetics in Iceland.

R Danielsen, F Jónasson, T Helgason.   

Abstract

The prevalence of retinopathy and proteinuria was assessed in 212 and 230 type 1 diabetics in Iceland respectively. They represent 78% and 84% of all such patients identified in the country. Retinopathy was present in 33.5%, background lesions only in 27.4% and more severe retinopathy in 6.1%. After 5-9 years of diabetes (mean 6.9) the prevalence of retinopathy was 18.8%, including 2.1% proliferative, and rose to 76.7% after 20 years or more of diabetes (mean 26.7), including 16.2% in the proliferative stage. Blindness was found in 2.4% of the patients. Diabetics diagnosed at the age of 0-19 years had a lower prevalence of retinopathy during their first 20 years of diabetes than those diagnosed later in life (p less than 0.05). Proteinuria was present in 14%, intermittent in 10% and continuous in 4%. After 10 years or more of diabetes (mean 19.3) the prevalence of intermittent and continuous proteinuria was 13.0% and 8.3%, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6758493     DOI: 10.1111/j.0954-6820.1982.tb03213.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  7 in total

1.  'Microalbuminuria' in type I (insulin-dependent) diabetic patients with and without retinopathy.

Authors:  R Miccoli; O Giampietro; G Penno; G Odello; R Anichini; A Bertolotto; L Cruschelli; S Bertoli; R Navalesi
Journal:  Acta Diabetol Lat       Date:  1989 Apr-Jun

Review 2.  Clinical Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

3.  A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients.

Authors:  G Joner; O Brinchmann-Hansen; C G Torres; K F Hanssen
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

4.  Biennial eye screening in patients with diabetes without retinopathy: 10-year experience.

Authors:  E Olafsdóttir; E Stefánsson
Journal:  Br J Ophthalmol       Date:  2007-07-12       Impact factor: 4.638

5.  Risk Factors for Diabetic Retinopathy among Jordanian Diabetics.

Authors:  Muawyah D Al-Bdour; Maha I Al-Till; Khawla M Abu Samra
Journal:  Middle East Afr J Ophthalmol       Date:  2008-04

6.  Longitudinal Screening for Diabetic Retinopathy in a Nationwide Screening Program: Comparing Deep Learning and Human Graders.

Authors:  Jirawut Limwattanayingyong; Variya Nganthavee; Kasem Seresirikachorn; Tassapol Singalavanija; Ngamphol Soonthornworasiri; Varis Ruamviboonsuk; Chetan Rao; Rajiv Raman; Andrzej Grzybowski; Mike Schaekermann; Lily H Peng; Dale R Webster; Christopher Semturs; Jonathan Krause; Rory Sayres; Fred Hersch; Richa Tiwari; Yun Liu; Paisan Ruamviboonsuk
Journal:  J Diabetes Res       Date:  2020-12-15       Impact factor: 4.011

Review 7.  The Diabetic Retinopathy Screening Workflow: Potential for Smartphone Imaging.

Authors:  Nigel M Bolster; Mario E Giardini; Andrew Bastawrous
Journal:  J Diabetes Sci Technol       Date:  2015-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.